申请人:Pfizer Inc.
                            
                            
                                公开号:US20020091117A1
                            
                            
                                公开(公告)日:2002-07-11
                            
                            The present invention relates to compounds of the formula
1
wherein R
1
, R
2
, R
3
, X, Y and the dashed line are defined as in the specification, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use. These compounds are useful as psychotherapeutic agents.
                            本发明涉及公式1的化合物,其中R1、R2、R3、X、Y和虚线在说明书中有定义,以及其制备的中间体,含有它们的制药组合物和它们的药用用途。这些化合物可用作心理治疗剂。